Skip to main content

Table 1 Access to care and HIV, HBV and HCV status at prison entry and during prison stay.

From: Harm reduction and equity of access to care for French prisoners: a review

  Mouquet Mouquet Remy Remy Drassif
  1997 (%) 2003 (%) 2000 (%) 2003 (%) 2005 (%)
  135 prisons Incoming inmates* 134 prisons Incoming inmates* 85 prisons 27 245 inmates** 88 prisons 31215 inmates** 8 prisons Incoming inmates***
HCV positive test 4.4a 4.2a 6.3b 6.9b 5.9 b
% of inmates screened 20 27 ND ND 38
HBV positive test 2.3a 0.8a    3.4 b
% of inmates screened 25 20    37
HIV positive test 1.6a 1.1a    0.6 b
% of inmates screened 46 40    41
HAART at prison entry 0.8 0.5    1.4
HCV treatment (total number/1 year)    164 297 171
  1. *study period : from 2 weeks to 3 months depending of the size of the prison
  2. ** cross-sectional study
  3. ***study period : 2005
  4. aself-reported serostatus among those who reported to have had already been screened
  5. b positive test